Your browser doesn't support javascript.
loading
Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China.
Li, Cheng; Zhou, Tao; Zhang, Peilin; He, Junning; Liu, Yongfang.
Affiliation
  • Li C; Department of Infectious Diseases, The Third People's Hospital of Chengdu, Chengdu, China.
  • Zhou T; Department of Infectious Diseases, The Third People's Hospital of Chengdu, Chengdu, China.
  • Zhang P; Department of Infectious Diseases, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • He J; Department of Infectious Diseases, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Liu Y; Department of Infectious Diseases, The Third People's Hospital of Chengdu, Chengdu, China.
Front Public Health ; 12: 1394762, 2024.
Article de En | MEDLINE | ID: mdl-38756875
ABSTRACT

Objective:

This study investigated the epidemiological and clinical characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected patients during the second pandemic of COVID-19 (coronavirus disease of 2019) in Chengdu, China. Furthermore, the differences between first infection and re-infection cases were also compared and analyzed to provide evidence for better prevention and control of SARS-CoV-2 re-infection.

Methods:

An anonymous questionnaire survey was conducted using an online platform (wjx.cn) between May 20, 2023 to September 12, 2023.

Results:

This investigation included 62.94% females and 32.97% of them were 18-30 years old. Furthermore, 7.19-17.18% of the participants either did not receive vaccination at all or only received full vaccination, respectively. Moreover, 577 (57.64%) participants were exposed to cluster infection. The clinical manifestations of these patients were mainly mild to moderate; 78.18% of participants had a fever for 1-3 days, while 37.84% indicated a full course of disease for 4-6 days. In addition, 40.66% of the participants had re-infection and 72.97% indicated their first infection approximately five months before. The clinical symptoms of the first SARS-CoV-2 infection were moderate to severe, while re-infection indicated mild to moderate symptoms (the severity of symptoms other than diarrhea and conjunctival congestion had statistically significant differences) (p < 0.05). Moreover, 70.53 and 59.21% of first and re-infection cases had fever durations of 3-5 and 0-2 days, respectively. Whereas 47.91 and 46.40% of first and re-infection cases had a disease course of 7-9 and 4-6 days.

Conclusion:

The SARS-CoV-2 infected individuals in Chengdu, China, during the second pandemic of COVID-19 had mild clinical symptoms and a short course of disease. Furthermore, compared with the first infection, re-infection cases had mild symptoms, low incidences of complications, short fever duration, and course of disease.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Front Public Health Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Front Public Health Année: 2024 Type de document: Article Pays d'affiliation: Chine